Eamonn Murphy

Eamonn Murphy is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as the Director of QC & AD at Matinas BioPharma since 2018. With extensive experience in analytical and compliance projects, Eamonn has held prominent roles at Teva Pharmaceuticals, Allergan, and Actavis plc, notably managing the Elemental Impurities compliance project across multiple laboratories. Eamonn's background includes establishing GMP labs, conducting method remediation for commercial products, and overseeing GLP projects at CarboGen AG. Eamonn holds a Ph.D. in Chemistry and has contributed significantly to the development and management of analytical services throughout a diverse career that began at academic institutions such as ETH Zurich and the University of Goettingen.